XML 43 R28.htm IDEA: XBRL DOCUMENT v3.19.1

12. Acquisition of Atlas Pharma Inc. (Tables)

12 Months Ended

Dec. 31, 2018

Acquisition Of Atlas Pharma Inc.

Acquisition

Cash		$	4,942
Accounts receivable		$	79,508
Prepaids		$	1,428
Property and equipment		$	62,990
Goodwill		$	665,697
Less: Liabilities assumed ($172,899 Canadian)		$	(137,817	)
Total consideration		$	676,748

X

- References

No definition available.

+ Details

Name:	SBFM_AcquisitionOfAtlasPharmaInc.Abstract
Namespace Prefix:	SBFM_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463

+ Details

Name:	us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration